Vestal Point Capital, LP Ptc Therapeutics, Inc. Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 90,000 shares of PTCT stock, worth $3.39 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
90,000Holding current value
$3.39 Million% of portfolio
0.21%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
215Shares Held
79.2MCall Options Held
122KPut Options Held
212K-
Vanguard Group Inc Valley Forge, PA8.97MShares$338 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$309 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$293 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$278 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$262 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.69B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...